98%
921
2 minutes
20
Background: Uterine fibroids are benign. They belong to the category of "abdominal mass" in traditional Chinese medicine, and pathogenesis is mainly caused by weakness of the body, qi stagnation, and blood stasis. Drug therapy is the preferred treatment of uterine fibroids in clinical practice, and mifepristone is the most commonly used drug. In the past decade, a large number of clinical randomized controlled trials have proven that Chinese patent medicine combined with mifepristone in the treatment of uterine fibroids has a better curative effect, fewer adverse reactions, and higher safety than mifepristone alone. However, there is a lack of evidence-based research. This study aims to integrate clinical data through network meta-analysis to provide more evidence-based medical evidence for clinical medication.
Methods: The comprehensive search included Chinese and other-language databases, such as MEDLINE (PubMed), Web of Science, The Cochrane Library, China National Knowledge Infrastructure, Wanfang Data Knowledge Service Platform, China Scientific Journal Database, and China Biomedical Literature Database. Clinical randomized controlled trials of 6 Chinese patent medicines combined with mifepristone for the treatment of uterine fibroids, including Guizhi Fuling Capsule, Gongliuxiao Capsule, Gongliuqing Capsule, Danbie Capsule, Gongliuning Capsule, and Xiaojiean Capsule were retrieved. The search period was from January 2010 to April 2021. Two researchers screened the literature through EndNote and used Excel to extract data. RevMan 5.3 was used to evaluate the quality of the literature. Treatment measures were analyzed in R language, and a forest map and probability ranking map of various interventions were drawn. The network evidence map and correction comparison funnel map of various interventions were drawn by STATA 14.0 software.
Results: This study provides the clinical efficacy and safety of network meta-analysis of 6 kinds of Chinese patent medicines combined with mifepristone in the treatment of uterine fibroids will be systematically evaluated or descriptively analyzed.
Conclusion: This study's purpose is to provide a reference for the clinical treatment of uterine fibroids to choose more effective intervention therapies.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8542145 | PMC |
http://dx.doi.org/10.1097/MD.0000000000027523 | DOI Listing |
Int J Surg Case Rep
September 2025
Department of Obstetrics and Gynaecology, Aga Khan Hospital, Dar es Salaam, Tanzania.
Introduction: Uterine fibroids are a common cause of infertility, and myomectomy remains a key surgical intervention to improve reproductive outcomes. However, the occurrence of an undetected pregnancy during myomectomy is rare and poses significant clinical risks.
Case Presentation: We report a 34-year-old woman, nulliparous with a history of secondary infertility and three first-trimester miscarriages.
JACC Case Rep
September 2025
Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland. Electronic address:
Background: Masses in the right ventricle are uncommon, but if present, they are most often attributed to either primary cardiac tumors or metastatic disease.
Case Summary: A 50-year-old woman presented with progressive lower extremity edema and was diagnosed with a right ventricular mass causing severe tricuspid insufficiency and near-total obstruction of the pulmonary artery. She had a history of hysterectomy for uterine leiomyomatosis.
Ultrasound Q
December 2025
Department of Radiology, Mayo Clinic, Jacksonville, FL.
Idiopathic scrotal calcinosis (ISC) is a rare, benign dermatological condition consisting of deposits of calcium within the scrotal skin. On examination, ISC is characterized by painless, firm nodules and papules localized to the scrotal skin. Typically presenting in adolescence or early adulthood, ISC is more prevalent in males aged 20 to 40, though cases have been reported across all age groups.
View Article and Find Full Text PDFJ Clin Ultrasound
September 2025
Clinic of Obstetrics and Gynecology, Sakarya Education and Research Hospital, Sakarya, Turkiye.
Hysteroscopic resection is considered the gold standard treatment for the removal of submucous uterine leiomyoma (SMLs). However, when hysteroscopic equipment is unavailable, alternative treatment approaches must be explored. In this case report, we present a video demonstrating the transcervical resection of an SML performed under transabdominal ultrasonography guidance on a patient with persistent abnormal uterine bleeding.
View Article and Find Full Text PDFFront Cardiovasc Med
August 2025
Department of Cardiovascular Surgery, Chengdu Shang Jin Nan Fu Hospital, West China Hospital of Sichuan University, Chengdu, Sichuan, China.
Background: Cardiac leiomyomas are extremely rare cardiac anomalies. Among them, primary leiomyomas confined to heart are even rarer, which have been reported only in few cases. Once diagnosed, surgical resection is the most common choice for treatment.
View Article and Find Full Text PDF